DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wu D, Yang XO.
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
J Microbiol Immunol Infect 2020;
DOI: 10.1016/j.jmii.2020.03.005.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.